Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $69.1 Million - $90.2 Million
-1,743,500 Reduced 18.36%
7,751,800 $401 Million
Q2 2024

Aug 15, 2024

BUY
$40.25 - $52.99 $215 Million - $283 Million
5,343,700 Added 128.71%
9,495,300 $394 Million
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $12.5 Million - $14.2 Million
-260,600 Reduced 5.91%
4,151,600 $225 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $79.6 Million - $95 Million
1,642,100 Added 59.28%
4,412,200 $226 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $52.4 Million - $58.6 Million
904,900 Added 48.51%
2,770,100 $161 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $43.1 Million - $47.8 Million
-675,900 Reduced 26.6%
1,865,200 $119 Million
Q1 2023

May 16, 2023

SELL
$65.71 - $74.53 $45.7 Million - $51.8 Million
-694,900 Reduced 21.47%
2,541,100 $176 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $5.31 Million - $6.28 Million
77,500 Added 2.45%
3,236,000 $233 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $10,738 - $6.35 Million
-82,600 Reduced 2.55%
3,158,500 $225 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.